Peri-Ovarian Mitochondrial Administration Improves Surrogate Markers Of Ovarian Function In Aged Rats: Free Versus Alginate-Encapsulated Mesenchymal Stromal Cell-Derived Mitochondria
As women age, their ovarian function naturally declines, leading to reduced fertility. A key factor contributing to this decline is often the diminishing health of mitochondria, the tiny powerhouses within our cells responsible for energy production and overall cell vitality.
Scientists are exploring innovative ways to combat this age-related decline. One promising approach involves transferring healthy mitochondria from one source to another. In a recent study, researchers investigated whether delivering mitochondria derived from mesenchymal stromal cells—a type of adult stem cell known for its regenerative properties—could improve ovarian health in aged rats.
The study compared two methods of delivery: administering the mitochondria freely or encapsulating them within tiny alginate hydrogel capsules, which act like protective bubbles. The findings revealed that both methods led to significant improvements in various markers of ovarian function. Specifically, treated rats showed a higher number of healthy egg-producing follicles, fewer degenerating follicles, and increased levels of estradiol, a crucial hormone for reproductive health.
Interestingly, the encapsulated mitochondria offered additional advantages, particularly in boosting antioxidant defenses and increasing markers of mitochondrial mass, suggesting enhanced cellular protection and energy production. This research highlights the potential of directly providing healthy mitochondria as a cell-free strategy to support and improve ovarian function during aging.
Source: link to paper